Analyst Ratings for Valeant Pharmaceuticals (vrx)

vrx Rating Summary

vrx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on vrx
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $95.09 (+185%) * Over Last 12-Mos
Rating Score: 4.6 / 10   Percentile Rank: 48%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/21/2016 Barclays Downgrade Equalweight
(Overweight)
34.00
(135.00)
26.98 33.36 23.65% Details
3/21/2016 Mizuho Securities
» Updated 4/28/2016
Downgrade Underperform
(Neutral)
18.00
(N/A)
26.98 33.36 23.65% Details
Like VRX Ratings? Also take a look at AGN, WBA, MNK, PRGO

VRX Ratings News